Cytokine Market Analysis

  • Report ID: 5867
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Cytokine Market Analysis

Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis);

In terms of therapeutic application, the cancer segment in the cytokine market is anticipated to hold 50% of the revenue share during the forecast period. There is an important role played in the development of cancer by a mixture of cytokine produced by the tumor microenvironment. Cytokine that respond to infection, inflammation, and immunity may be able to slow down the development of cancer. The growth of the market is supported by factors such as an increased incidence of cancer, research and funding for treatment. According to Globocan 2020, there were 19,292,789 new cases of cancer in the world. By 2040, this number is expected to rise to 28,887,940.In addition, cytokine market growth is boosted by the presence of competitors, product launches, collaboration and pipeline assets as well as research.

Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-Il, Interferons-IFN, Epidermal Growth Factor-EGF)

In terms of cytokine type, the tumor necrosis factor - TNF segment is in the cytokine market is anticipated to hold 40% of the revenue share during the forecast period.Tumor necrosis factor-alpha is one of the first cytokine to be discovered. When administered locally, it helps to trigger the pro-inflammatory response against pathogens and mainly affects leukocytes and vascular endothelial cells. In addition, TNF cytokine are beneficial in the case of cell apoptosis, cachexia, proliferation, differentiation, lipid metabolism and coagulation. processes. Infliximab, golimumab, etanercept, enbrel and tasonermin are some of the key TNF based medicinal products. The growth is due to an increase in the incidence of cardiovascular and oncology related diseases. TNF has been studied in a number of diseases, mainly for cardiac and cancer related indications. Many biopharmaceutical companies are associated in the research and development of TNF inhibitory medications.

Our in-depth analysis of the global cytokine market includes the following segments:

          Cytokine Type

  • Tumor Necrosis Factor-TNF
  • Interleukins-Il
  • Interferons-IFN
  • Epidermal Growth Factor-EGF

         Therapeutic Application

  • Cancer
  • Asthma and Airway Inflammation
  • Arthritis

         End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization
  • Academic & Research Institutes
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5867
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cytokine is evaluated at USD 93.96 billion.

Cytokine Market size was valued at USD 88.57 billion in 2024 and is expected to exceed USD 229.53 billion by the end of 2037, expanding at over 7.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of cancer and increasing research and development activities will drive the market growth.

North America industry is poised to dominate majority revenue share of 35% by 2037, due to rising substantial prevalence of chronic diseases in the region.

The major players in the market are of Pfizer Inc., Biocon Limited, Amgen Inc, GlaxoSmithKline PLC, General Electric Company, Johnson & Johnson, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample